Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (TA139)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 August 2021Published: 26 March 2008
Daridorexant for treating long-term insomnia (TA922)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 October 2023
Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea (IPG760)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 19 April 2023
Eszopiclone for treating insomnia TS ID 12020Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (TA77)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 April 2004
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndromeStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 19 December 2024
Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoea (IPG598)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 November 2017
Melatonin for treating sleep disorders in adults who are blind (ES38)Product type:AdviceProgramme:Evidence summaryPublished: 18 August 2021
Narcolepsy with or without cataplexy in adults: pitolisant (ES8)Product type:AdviceProgramme:Evidence summaryPublished: 14 March 2017
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)Product type:GuidanceProgramme:NICE guidelinePublished: 20 August 2021
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA776)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 March 2022
Radiofrequency ablation of the soft palate for snoring (IPG476)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 January 2014
Remedē System (Respicardia Inc) for transvenous stimulation of the phrenic nerve towards the tehrapy of Central sleep apnoea - moderate to severeStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Sleepio to treat insomnia and insomnia symptoms (MTG70)Product type:GuidanceProgramme:Medical technologies guidancePublished: 20 May 2022
Soft-palate implants for obstructive sleep apnoea (IPG241)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 November 2007
Soft-palate implants for simple snoring (IPG240)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 November 2007
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy (TA758)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 January 2022
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA777)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 March 2022
SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea (MIB190)Product type:AdviceProgramme:Medtech innovation briefingPublished: 9 September 2019
Transcutaneous electrical stimulation of the upper airway dilator muscles for obstructive sleep apnoeaStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC